← Eichor
Condition: Secondary Osteoarthritis Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Secondary Osteoarthritis

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

The Beat Pain Better Trial
Phase 3 · 3 location(s) · University of Utah · NCT06932887Calcaneocuboid Arthrodesis in Triple Arthrodesis by Plate Versus Screw: Randomized Controlled Trial
NA · 1 location(s) · Assiut University · NCT06003296Early Feasibility Study of Cartilage Defect Repair
NA · 1 location(s) · Cytex Therapeutics, Inc. · NCT06823089Clinical and Radiological Outcomes of Medacta Shoulder System FR
Phase N/A · 1 location(s) · Medacta International SA · NCT05926622Clinical Study of Myofascial Trigger Points(MTrPs) Injection in the Treatment of Knee Osteoarthritis(OA)
NA · 1 location(s) · Beijing Tiantan Hospital · NCT07347028Observational Study to Evaluate Long-Term Outcome in Hip Arthroplasty
Phase N/A · 13 location(s) · Corin · NCT02230826Preoperative Genicular Radiofrequency and Functional Outcomes After Total Knee Arthroplasty
NA · 1 location(s) · Anesthesiology department Iris South Hospitals · NCT07727551Prognostic Factors in Zygapophyseal Osteoarthritis Infiltration: a Prospective Cohort Study
Phase N/A · 1 location(s) · Hospital Israelita Albert Einstein · NCT03304730Transforming Rehabilitation: Personalised Care for a Better Quality of Life
Phase N/A · 1 location(s) · I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · NCT06249958
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.